Follow The Filings

RAPP Rapport Therapeutics Inc.

Health Care, filed as RAPPORT THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.6%
  • $3.1M

Who owns this now

Largest portfolio weights among holders, up to 0.6% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.60%

Who owns RAPP

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.60% Hold 75,000 $3.1M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RAPP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RAPP insider trades
  • $1.6M bought by 5 insiders
  • None no sales outside a trading plan
  • $46.8M sold by 5 insiders under 10b5-1 plans
  1. Paul M Silva Director
    Buy
    $100K 3,680 shares at $27.08 New stake
    Traded Oct 22 Filed Oct 22
    ↗
  2. Wendy B. Young Director
    Buy
    $100K 3,789 shares at $26.39 +40% to stake
    Traded Oct 22 Filed Oct 22
    ↗
  3. Steven M Paul Director
    Buy
    $974K 35,714 shares at $27.28 +86% to stake
    Traded Oct 22 Filed Oct 22
    ↗
  4. John Maraganore Director
    Buy
    $249K 9,411 shares at $26.45 New stake
    Traded Oct 22 Filed Oct 22
    ↗
  5. Troy A. Ignelzi CFO
    Buy
    $144K 5,500 shares at $26.10 +55% to stake
    Traded Oct 21 Filed Oct 21
    ↗
  6. Abraham Ceesay CEO
    Planned sale
    $143K 4,522 shares at $31.68 1% of stake
    Traded Oct 6–7 Filed Oct 8
    ↗
  7. Cheryl Gault COO
    Planned sale
    $332K 10,000 shares at $33.19 6.7% of stake
    Traded Sep 30 Filed Oct 1
    ↗
  8. Abraham Ceesay CEO
    Planned sale
    $87K 2,210 shares at $39.17 0.5% of stake
    Traded Sep 23 Filed Sep 24
    ↗
  9. Abraham Ceesay CEO
    Planned sale
    $374K 8,210 shares at $45.61 1.8% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  10. Abraham Ceesay CEO
    Planned sale
    $938K 18,921 shares at $49.57 3.9% of stake
    Traded Aug 25 Filed Aug 26
    ↗
  11. Krishnaswamy Yeleswaram Chief Development Officer
    Planned sale
    $2.5M 50,160 shares at $50.47 20% of stake
    Traded Aug 24–25 Filed Aug 26
    ↗
  12. Krishnaswamy Yeleswaram Chief Development Officer
    Planned sale
    $20K 404 shares at $49.90 0.2% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  13. Abraham Ceesay CEO
    Planned sale
    $2.4M 51,499 shares at $47.25 9.6% of stake
    Traded Aug 10–11 Filed Aug 12
    ↗
  14. Abraham Ceesay CEO
    Planned sale
    $93K 2,210 shares at $42.11 0.4% of stake
    Traded Jul 27 Filed Jul 29
    ↗
  15. Abraham Ceesay CEO
    Planned sale
    $328K 8,210 shares at $40.00 1.5% of stake
    Traded Jul 14 Filed Jul 15
    ↗

Also filed in the last 12 months, not counted as buying or selling: 3 sales to cover taxes, 2 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated about 20 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Net income -$78.31M -$111.48M

Balance sheet

Metric FY2024 FY2025
Total current assets $309.8M $498.56M
Total non-current assets * $5.13M $13.87M
Total assets $314.93M $512.43M
Total current liabilities $8.77M $19.05M
Total non-current liabilities * $0.739M $8.73M
Total equity $305.43M $484.65M

Cash flow

Metric FY2024 FY2025
Cash from operations -$64.83M -$87.47M
Cash from investing -$170.14M -$187.47M
Cash from financing $221.62M $270.79M
Net change in cash -$13.34M -$4.16M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.